392 related articles for article (PubMed ID: 19124934)
1. Prevention of no flow/slow reflow phenomenon in primary PCI by Nicorandil.
J E; Juneja MS; George T; Sr R; V V; Ak B; Kalyani S; Pandurangi UM; Latchumanadhas K; S MA
Indian Heart J; 2007; 59(3):246-9. PubMed ID: 19124934
[TBL] [Abstract][Full Text] [Related]
2. Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction.
Fu XH; Fan WZ; Gu XS; Wei YY; Jiang YF; Wu WL; Li SQ; Hao GZ; Wei QM; Xue L
Chin Med J (Engl); 2007 Jul; 120(14):1226-31. PubMed ID: 17697572
[TBL] [Abstract][Full Text] [Related]
3. Treatment of slow/no-reflow phenomenon with intracoronary nitroprusside injection in primary coronary intervention for acute myocardial infarction.
Wang HJ; Lo PH; Lin JJ; Lee H; Hung JS
Catheter Cardiovasc Interv; 2004 Oct; 63(2):171-6. PubMed ID: 15390241
[TBL] [Abstract][Full Text] [Related]
4. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
[TBL] [Abstract][Full Text] [Related]
5. Transradial application of PercuSurge GuardWire device during primary percutaneous intervention of infarct-related artery with high-burden thrombus formation.
Yip HK; Chen MC; Chang HW; Kuo FY; Yang CH; Chen SM; Hung WC; Chen CJ; Cheng CI; Wu CJ
Catheter Cardiovasc Interv; 2004 Apr; 61(4):503-11. PubMed ID: 15065147
[TBL] [Abstract][Full Text] [Related]
6. Effect of tirofiban plus clopidogrel and aspirin on primary percutaneous coronary intervention via transradial approach in patients with acute myocardial infarction.
Fu XH; Hao QQ; Jia XW; Fan WZ; Gu XS; Wu WL; Hao GZ; Li SQ; Jiang YF; Geng W
Chin Med J (Engl); 2008 Mar; 121(6):522-7. PubMed ID: 18364139
[TBL] [Abstract][Full Text] [Related]
7. Impact of reversibility of no reflow phenomenon on 30-day mortality following percutaneous revascularization for acute myocardial infarction-insights from a 1,328 patient registry.
Lee CH; Wong HB; Tan HC; Zhang JJ; Teo SG; Ong HY; Low A; Sutandar A; Lim YT
J Interv Cardiol; 2005 Aug; 18(4):261-6. PubMed ID: 16115155
[TBL] [Abstract][Full Text] [Related]
8. Intracoronary nitroprusside in the prevention of the no-reflow phenomenon in acute myocardial infarction.
Pan W; Wang LF; Yu JH; Fan Y; Yang SS; Zhou LJ; Li Y; Li WM
Chin Med J (Engl); 2009 Nov; 122(22):2718-23. PubMed ID: 19951602
[TBL] [Abstract][Full Text] [Related]
9. Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: role of inhibitory effect on reactive oxygen species formation.
Ono H; Osanai T; Ishizaka H; Hanada H; Kamada T; Onodera H; Fujita N; Sasaki S; Matsunaga T; Okumura K
Am Heart J; 2004 Oct; 148(4):E15. PubMed ID: 15459610
[TBL] [Abstract][Full Text] [Related]
10. Intracoronary boluses of adenosine and sodium nitroprusside in combination reverses slow/no-reflow during angioplasty: a clinical scenario of ischemic preconditioning.
Parikh KH; Chag MC; Shah KJ; Shah UG; Baxi HA; Chandarana AH; Naik AM; Shah JN; Shah HD; Goyal RK
Can J Physiol Pharmacol; 2007; 85(3-4):476-82. PubMed ID: 17612657
[TBL] [Abstract][Full Text] [Related]
11. No-reflow phenomenon after acute myocardial infarction is associated with reduced clot permeability and susceptibility to lysis.
Zalewski J; Undas A; Godlewski J; Stepien E; Zmudka K
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2258-65. PubMed ID: 17673704
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization.
Niccoli G; Lanza GA; Shaw S; Romagnoli E; Gioia D; Burzotta F; Trani C; Mazzari MA; Mongiardo R; De Vita M; Rebuzzi AG; Lüscher TF; Crea F
Eur Heart J; 2006 Aug; 27(15):1793-8. PubMed ID: 16829540
[TBL] [Abstract][Full Text] [Related]
13. Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial.
Amit G; Cafri C; Yaroslavtsev S; Fuchs S; Paltiel O; Abu-Ful A; Weinstein JM; Wolak A; Ilia R; Zahger D
Am Heart J; 2006 Nov; 152(5):887.e9-14. PubMed ID: 17070151
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome of percutaneous coronary intervention with antecedent mutant t-PA administration for acute myocardial infarction.
Kurihara H; Matsumoto S; Tamura R; Yachiku K; Nakata A; Nakagawa T; Yoshino T; Matsuyama T
Am Heart J; 2004 Apr; 147(4):E14. PubMed ID: 15077097
[TBL] [Abstract][Full Text] [Related]
15. Acute effects of isosorbide dinitrate and nicorandil on the coronary slow flow phenomenon.
Sadamatsu K; Tashiro H; Yoshida K; Shikada T; Iwamoto K; Morishige K; Yoshidomi Y; Tokunou T; Tanaka H
Am J Cardiovasc Drugs; 2010; 10(3):203-8. PubMed ID: 20524721
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of nitroprusside versus nicorandil on the slow/no-reflow phenomenon during coronary interventions for acute myocardial infarction.
Kobatake R; Sato T; Fujiwara Y; Sunami H; Yoshioka R; Ikeda T; Saito H; Ujihira T
Heart Vessels; 2011 Jul; 26(4):379-84. PubMed ID: 21110199
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of PercuSurge in acute myocardial infarction patients undergoing revascularization with a special emphasis on procedural time.
Parikh KH; Shah HA; Chag MC; Shah UG; Baxi HA; Chandarana AH; Naik AM; Shah JN; Goyal RK
Indian Heart J; 2008; 60(2):101-19. PubMed ID: 19218717
[TBL] [Abstract][Full Text] [Related]
18. Prevention of distal embolization and no-reflow in patients with acute myocardial infarction and total occlusion in the infarct-related vessel: a subgroup analysis of the cohort of acute revascularization in myocardial infarction with excimer laser-CARMEL multicenter study.
Dahm JB; Ebersole D; Das T; Madyhoon H; Vora K; Baker J; Hilton D; Topaz O
Catheter Cardiovasc Interv; 2005 Jan; 64(1):67-74. PubMed ID: 15619312
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience with a novel intracoronary perfusion catheter to treat no-reflow phenomenon in acute coronary syndromes.
Maluenda G; Ben-Dor I; Delhaye C; Gonzalez MA; Collins SD; Torguson R; Xue Z; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
J Interv Cardiol; 2010 Apr; 23(2):109-13. PubMed ID: 20337859
[TBL] [Abstract][Full Text] [Related]
20. Intensive cholesterol lowering with statin improves the outcomes of percutaneous coronary intervention in patients with acute coronary syndrome.
Jia XW; Fu XH; Zhang J; Gu XS; Fan WZ; Wu WL; Hao GZ; Li SQ; Jiang YF
Chin Med J (Engl); 2009 Mar; 122(6):659-64. PubMed ID: 19323930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
